The Global Fund to Fight AIDS, Tuberculosis and Malaria made public the final report of an independent evaluation of the pilot phase of the Affordable Medicines Facility–malaria, also known as AMFm, on 4 October 2012.
The Global Fund commissioned the independent evaluation to assess the extent to which AMFm has achieved the main objectives laid out for its pilot phase, which ends in December 2012. The independent evaluation was mandated by the Global Fund Board and will inform its decision in November 2012, when the Board is expected to consider the future of AMFm beyond the pilot phase.
The final report is now available (blue box above in the right). This report is an update to the preliminary report that was released in July 2012.
The goal of AMFm is to improve access to artemisinin-based combination therapies (ACTs), the most effective anti-malaria treatment. The AMFm pilot phase was launched in April 2009 and began operations in July 2010. It set out to increase availability, particularly through private outlets where most people seek their treatments, and drive down the price of ACTs through a factory-gate global subsidy of ACTs combined with country-level measures to support its implementation.
The AMFm pilot phase currently operates in eight countries: Cambodia, Ghana, Kenya, Madagascar, Niger, Nigeria, Tanzania, and Uganda. The independent evaluation assessed the program in each of the pilot countries that was operational at the time of the endline survey.
To date, AMFm has subsidized over 300 million ACT treatments. This global subsidy is financed through contributions of US$336 million from UNITAID, the governments of the United Kingdom and Canada, and the Bill & Melinda Gates Foundation. Technical support is provided by members of the Roll Back Malaria Partnership.
The independent evaluation of the AMFm pilot phase was led by a consortium of ICF International and the London School of Hygiene and Tropical Medicine, which were contracted through a competitive tender process. In addition, the Global Fund contracted Data Contributors that were responsible for the fieldwork, data analysis, and country reports.
Supplementary Report on ACT Use Based on Household Surveys
[PDF - 982 KB]
AMFm Expert Advisory Group Meeting Report 22 June 2012
[PDF - 630 KB]
Appendices to Final Report
[PDF - 3025 KB]
Final Report without Appendices
[PDF - 6285 KB]
Full Final Report with Appendices
[PDF - 9207 KB]
Executive Summary of Final Report
[PDF - 1095 KB]
Overview of Final Report
[PDF - 463 KB]
Contact | Report Fraud and Abuse | Legal | RSS | Sitemap
© 2013 The Global Fund to Fight AIDS, Tuberculosis and Malaria